Loading insider details...
Beta
Latest Form 4 (Feb 27, 2026): Disposition to Issuer of 165,296 RNAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 165,296 | n/a |
| Jan 23, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 1,476 | $106.9K |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 1,965 | $141.9K |
| Dec 19, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 39,000 | n/a |
| Oct 17, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 20,000 | $446.8K |
| Sep 17, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 15,000 | $335.1K |
| Aug 15, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 10,000 | $223.4K |
| Mar 21, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 7,778 | $241.6K |
| Jan 24, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 1,738 | $49.7K |
| Jan 9, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 25,000 | n/a |